Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alise S Reicin

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The American Journal of Cardiology|January 17, 2002
Comparison of cardiovascular thrombotic events in patients with osteoarthritis treated with rofecoxib versus nonselective nonsteroidal anti-inflammatory drugs (ibuprofen, diclofenac, and nabumetone)Alise S Reicin, Deborah Shapiro, Rhoda S Sperling, et al.
Current Medical Research and Opinion|October 7, 2004
The upper gastrointestinal safety of rofecoxib vs. NSAIDs: an updated combined analysisDouglas J Watson, Qinfen Yu, James A Bolognese, et al.
Current Medical Research and Opinion|February 3, 2007
Pooled analysis of thrombotic cardiovascular events in clinical trials of the COX-2 selective Inhibitor etoricoxibSean P Curtis, Amy T Ko, James A Bolognese, et al.
BMC Musculoskeletal Disorders|December 3, 2005
Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial [NCT00242489]Sean P Curtis, Barry Bockow, Chester Fisher, et al.
Clinical Therapeutics|March 5, 2004
Renal effects of etoricoxib and comparator nonsteroidal anti-inflammatory drugs in controlled clinical trialsSean P Curtis, Jennifer Ng, Qinfen Yu, et al.
Current Medical Research and Opinion|June 25, 2005
The incidence of upper gastrointestinal adverse events in clinical trials of etoricoxib vs. non-selective NSAIDs: an updated combined analysisDena R Ramey, Douglas J Watson, Chang Yu, et al.
Blood|November 18, 2005
Evaluation of the efficacy and safety of etoricoxib in the treatment of hemophilic arthropathyChristos Tsoukas, M Elaine Eyster, Sumiko Shingo, et al.
Anesthesia and Analgesia|September 30, 2005
Etoricoxib provides analgesic efficacy to patients after knee or hip replacement surgery: a randomized, double-blind, placebo-controlled studyG Lynn Rasmussen, Kerstin Malmstrom, Michael H Bourne, et al.
Mayo Clinic Proceedings|April 12, 2005
Evaluation of the comparative efficacy of etoricoxib and ibuprofen for treatment of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trialCraig W Wiesenhutter, Judith A Boice, Amy Ko, et al.
Pain|June 30, 2009
fMRI investigation of the effect of local and systemic lidocaine on noxious electrical stimulation-induced activation in spinal cordFuqiang Zhao, Mangay Williams, Denise C Welsh, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The American Journal of Cardiology|January 17, 2002
Comparison of cardiovascular thrombotic events in patients with osteoarthritis treated with rofecoxib versus nonselective nonsteroidal anti-inflammatory drugs (ibuprofen, diclofenac, and nabumetone)Alise S Reicin, Deborah Shapiro, Rhoda S Sperling, et al.
Current Medical Research and Opinion|October 7, 2004
The upper gastrointestinal safety of rofecoxib vs. NSAIDs: an updated combined analysisDouglas J Watson, Qinfen Yu, James A Bolognese, et al.
Current Medical Research and Opinion|February 3, 2007
Pooled analysis of thrombotic cardiovascular events in clinical trials of the COX-2 selective Inhibitor etoricoxibSean P Curtis, Amy T Ko, James A Bolognese, et al.
BMC Musculoskeletal Disorders|December 3, 2005
Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial [NCT00242489]Sean P Curtis, Barry Bockow, Chester Fisher, et al.
Clinical Therapeutics|March 5, 2004
Renal effects of etoricoxib and comparator nonsteroidal anti-inflammatory drugs in controlled clinical trialsSean P Curtis, Jennifer Ng, Qinfen Yu, et al.
Current Medical Research and Opinion|June 25, 2005
The incidence of upper gastrointestinal adverse events in clinical trials of etoricoxib vs. non-selective NSAIDs: an updated combined analysisDena R Ramey, Douglas J Watson, Chang Yu, et al.
Blood|November 18, 2005
Evaluation of the efficacy and safety of etoricoxib in the treatment of hemophilic arthropathyChristos Tsoukas, M Elaine Eyster, Sumiko Shingo, et al.
Anesthesia and Analgesia|September 30, 2005
Etoricoxib provides analgesic efficacy to patients after knee or hip replacement surgery: a randomized, double-blind, placebo-controlled studyG Lynn Rasmussen, Kerstin Malmstrom, Michael H Bourne, et al.
Mayo Clinic Proceedings|April 12, 2005
Evaluation of the comparative efficacy of etoricoxib and ibuprofen for treatment of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trialCraig W Wiesenhutter, Judith A Boice, Amy Ko, et al.
Pain|June 30, 2009
fMRI investigation of the effect of local and systemic lidocaine on noxious electrical stimulation-induced activation in spinal cordFuqiang Zhao, Mangay Williams, Denise C Welsh, et al.
Pageof 2